SERINC as a Restriction Factor to Inhibit Viral Infectivity and the Interaction with HIV

Abstract EN

The serine incorporator 5 (SERINC5) is a recently discovered restriction factor that inhibits viral infectivity by preventing fusion.

Retroviruses have developed strategies to counteract the action of SERINC5, such as the expression of proteins like negative regulatory factor (Nef), S2, and glycosylated Gag (glycoGag).

These accessory proteins downregulate SERINC5 from the plasma membrane for subsequent degradation in the lysosomes.

The observed variability in the action of SERINC5 suggests the participation of other elements like the envelope glycoprotein (Env) that modulates susceptibility of the virus towards SERINC5.

The exact mechanism by which SERINC5 inhibits viral fusion has not yet been determined, although it has been proposed that it increases the sensitivity of the Env by exposing regions which are recognized by neutralizing antibodies.

More studies are needed to understand the role of SERINC5 and to assess its utility as a therapeutic strategy.